Science Explorer Back to mapMap
Discussion
Institution · Rainier Clinical Research Center

Most cited papers from Rainier Clinical Research Center

Rainier Clinical Research Center

What are the most cited papers from Rainier Clinical Research Center?

The most cited paper from Rainier Clinical Research Center is "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" (Timothy Silleck Bailey, Bruce W. Bode, Mark P. Christiansen et al., 2015), with 694 citations. Next come "Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes" (585) and "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study" (516).

Showing 50 of 96 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System Timothy Silleck Bailey, Bruce W. Bode, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics Open access 14 Jul 2015 694
2 Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes Satish K. Garg, Stuart A. Weinzimer, William V. Tamborlane et al. · Diabetes Technology & Therapeutics Open access 30 Jan 2017 585
3 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Julio Rosenstock, Ronald Brazg, Paula J. Andryuk et al. · Clinical Therapeutics Oct 2006 516
4 Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes Julio Rosenstock, Leslie J. Klaff, Sherwyn Leon Schwartz et al. · Diabetes Care Open access 23 Mar 2010 232
5 Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System Richard L. Weinstein, Sherwyn Leon Schwartz, Ronald Brazg et al. · Diabetes Care 27 Apr 2007 227
6 Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes Anders L. Carlson et al. · Diabetes Technology & Therapeutics Open access 25 Oct 2021 225
7 Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII Irl B. Hirsch, Bruce W. Bode, Satish K. Garg et al. · Diabetes Care Mar 2005 200
8 A Continuous Glucose Sensor Based on Wired Enzyme ™ Technology - Results from a 3-Day Trial in Patients with Type 1 Diabetes Ben Feldman, Ronald Brazg, Sherwyn Leon Schwartz et al. · Diabetes Technology & Therapeutics Oct 2003 184
9 Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes Shridhara Alva, Timothy Silleck Bailey, Ronald Brazg et al. · Journal of Diabetes Science and Technology Open access 19 Sep 2020 161
10 Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor Mark P. Christiansen, Satish K. Garg, Ronald Brazg et al. · Diabetes Technology & Therapeutics Open access 12 Jul 2017 153
11 Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors David C. Klonoff, Joan Lee Parkes, Boris P. Kovatchev et al. · Diabetes Care 13 Jun 2018 149
12 A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II Mark P. Christiansen, Leslie J. Klaff, Ronald Brazg et al. · Diabetes Technology & Therapeutics Open access 30 Jan 2018 148
13 Studies of a Family with the Oral-Facial-Digital Syndrome Theodore C. Doege, Horace C. Thuline, Jean H. Priest et al. · New England Journal of Medicine 19 Nov 1964 141
14 Effect of adding sitagliptin, a dipeptidyl peptidase‐4 inhibitor, to metformin on 24‐h glycaemic control and β‐cell function in patients with type 2 diabetes Ronald Brazg, Lei Xu, Chiara Dalla Man et al. · Diabetes Obesity and Metabolism 15 Dec 2006 138
15 Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study Satish K. Garg, Ronald Brazg, Timothy Silleck Bailey et al. · Diabetes Technology & Therapeutics 8 Feb 2012 137
16 Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes Laurence J Hirsch, Michael A. Gibney, John Albanese et al. · Current Medical Research and Opinion 30 Apr 2010 110
17 MR imaging of rotator cuff tears in individuals with paraplegia. Eva M. Escobedo, John C. Hunter, Mark C. Hollister et al. · American Journal of Roentgenology Apr 1997 108
18 Efficacy and Safety of Combination Therapy Philip Raskin, Leslie J. Klaff, Janet B. McGill et al. · Diabetes Care Jul 2003 102
19 Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor Timothy Silleck Bailey, Andrew Ahmann, Ronald Brazg et al. · Diabetes Technology & Therapeutics 7 Apr 2014 101
20 Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms Desmond Barry Keenan, John J. Mastrototaro, Howard Zisser et al. · Diabetes Technology & Therapeutics 6 Dec 2011 100
21 Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial Satish K. Garg, Emily G. Moser, Bruce W. Bode et al. · Endocrine Practice 28 Nov 2012 99
22 Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study Leslie J. Klaff, Dachuang Cao, Mary Anne Dellva et al. · Diabetes Obesity and Metabolism Open access 3 Jun 2020 92
23 Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study Satish K. Garg, David R. Liljenquist, Bruce W. Bode et al. · Diabetes Technology & Therapeutics Open access 13 Sep 2021 84
24 Performance of a Glucose Meter with a Built-in Automated Bolus Calculator versus Manual Bolus Calculation in Insulin-Using Subjects Allen Sussman, Elizabeth Johnston Taylor, Mona Patel et al. · Journal of Diabetes Science and Technology Open access Mar 2012 82
25 A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes Yogish C. Kudva et al. · New England Journal of Medicine 19 Mar 2025 75
26 Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM Orville Kolterman, Sherwyn Leon Schwartz, C. Corder et al. · Diabetologia Apr 1996 74
27 Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System Shridhara Alva, Ronald Brazg, KRISTIN N. CASTORINO et al. · Diabetes Therapy Open access 6 Mar 2023 70
28 Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study Halis Kaan Aktürk, Janet K. Snell‐Bergeon, Amanda H. Rewers et al. · Diabetes Technology & Therapeutics Open access 12 Sep 2018 68
29 Performance Variability of Seven Commonly Used Self-Monitoring of Blood Glucose Systems: Clinical Considerations for Patients and Providers Ronald Brazg, Leslie J. Klaff, Christopher G. Parkin · Journal of Diabetes Science and Technology Open access 2013 68
30 Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumors: lesion conspicuity and extent. William P. Shuman, Randall M. Patten, RICHARD L. BARON et al. · Radiology Apr 1991 66
31 Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial Satish K. Garg et al. · Diabetes Technology & Therapeutics Open access 6 Dec 2022 63
32 A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study Mark P. Christiansen, Leslie J. Klaff, Timothy Silleck Bailey et al. · Diabetes Technology & Therapeutics Open access 29 Mar 2019 63
33 A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin Donald B. Hunninghake, Mark E. McGovern, Michael J. Koren et al. · Clinical Cardiology Open access Mar 2003 59
34 Lack of Association between Cirrhosis and the Common Types of Color Blindness Philip J. Fialkow, Horace C. Thuline, Laura Fenster · New England Journal of Medicine 15 Sep 1966 58
35 Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial Jeremy Pettus, SCHAFER C. BOEDER, Mark P. Christiansen et al. · Nature Medicine Open access Oct 2022 57
36 FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart Algorithm, a 1-Hour Warm-up Time Geoffrey V. McGarraugh, Ronald Brazg, Richard L. Weinstein · Journal of Diabetes Science and Technology Open access 2011 57
37 Evaluation of a Flow Cytometry‐Based Assay for Natural Killer Cell Activity in Clinical Settings Ranjini Valiathan, JH Lewis, Angelica B. Melillo et al. · Scandinavian Journal of Immunology Open access 12 Dec 2011 56
38 Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients Mark Warren, Martin J. Conway, Leslie J. Klaff et al. · Diabetes Research and Clinical Practice 5 Aug 2004 55
39 Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical Trial William Insull, Jonathan L. Isaacsohn, Peter O. Kwiterovich et al. · Journal of International Medical Research Apr 2000 54
40 Evaluation of a Predictive Low-Glucose Management System In-Clinic Bruce A. Buckingham, Timothy Silleck Bailey, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics 16 Feb 2017 53
41 Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer Joan H. Schiller, Joachim von Pawel, Philipp Schütt et al. · Journal of Thoracic Oncology Open access 26 Oct 2010 51
42 Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems Manuel Eichenlaub et al. · Diabetes Technology & Therapeutics Open access 9 Jan 2024 49
43 Accuracy Evaluation of Contour Next Compared with Five Blood Glucose Monitoring Systems Across a Wide Range of Blood Glucose Concentrations Occurring in a Clinical Research Setting Leslie J. Klaff, Ronald Brazg, Kristen Hughes et al. · Diabetes Technology & Therapeutics 26 Sep 2014 45
44 Educating Industrial–Organizational Psychologists for Science and Practice: Where Do We Go From Here? Zinta S. Byrne, Theodore L. Hayes, Stuart McPhail et al. · Industrial and Organizational Psychology 21 Feb 2014 41
45 Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen Richard M. Bergenstal et al. · Diabetes Technology & Therapeutics Open access 26 Apr 2019 36
46 Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-Label, dose-escalation study Ronald A. Thisted, Leslie J. Klaff, Sherwyn Leon Schwartz et al. · Clinical Therapeutics Oct 2006 33
47 The Effect of an Aloe Polymannose Multinutrient Complex on Cognitive and Immune Functioning in Alzheimer's Disease John Eugene Lewis, H. Reginald McDaniel, Marc Agronin et al. · Journal of Alzheimer s Disease 17 Dec 2012 32
48 Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Robert H. Slover, Jeanie B. Tryggestad, Linda Anne DiMeglio et al. · Diabetes Technology & Therapeutics 31 Jul 2018 31
49 The use of psychopharmacologic agents in retarded children with behavior disorders Gerald D. LaVeck, Phyllis Buckley · Journal of Chronic Diseases Feb 1961 30
50 The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia Ronald Brazg, Timothy Silleck Bailey, Satish K. Garg et al. · Journal of Diabetes Science and Technology Open access Nov 2011 28

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.